Bartholomew Drug Company
Pharmacy
315 S Main St, Rock Port
Missouri, 64482-1533
660-744-2343 660-744-2433
Bartholomew Drug Company is an authorized DME supplier for medicare equipments and products.
Bartholomew Drug Company is a Pharmacy in Rock Port, Missouri. It is located at 315 S Main St, Rock Port and it's customer support contact number is 660-744-2343. The authorized person of Bartholomew Drug Company is Colby Haynes who is Vice President of the pharmacy and his contact number is 402-335-3375. Active license number of Bartholomew Drug Company is 002402 for Pharmacy in Missouri. Bartholomew Drug Company accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Bartholomew Drug Company is a facility used by pharmacists for the compounding and dispensing of medicinal preparations and other associated professional and administrative services. A pharmacy is a facility whose primary function is to store, prepare and legally dispense prescription drugs under the professional supervision of a licensed pharmacist. It meets any licensing or certification standards set forth by the jurisdiction where it is located.
Pharmacy Details:
Bartholomew Drug Company type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Bartholomew Drug Company |
| Type: | Pharmacy |
| Location: | 315 S Main St, Rock Port, Missouri, 64482-1533 |
| Phone: | 660-744-2343 |
| Fax: | 660-744-2433 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Colby Haynes |
| Position: | Vice President |
| Contact Number: | 402-335-3375 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1255407912 |
| NPI Enumeration Date: | 27 Nov, 2006 |
| NPI Last Update On: | 18 Oct, 2019 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Bartholomew Drug Company are as mentioned below.
| Specialization | License Number | State | Status | |
| Pharmacy | 002402 | Missouri | Primary | |
| Long Term Care Pharmacy | | | Secondary | |
| Durable Medical Equipment & Medical Supplies | | | Secondary | |
| Community/Retail Pharmacy | | | Secondary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 60007406 | Medicaid | Missouri | |
| 2609723 | Other | | Other Id Number-commercial Number |
Medicare Enrollment:
Bartholomew Drug Company is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 5294854949 | O20100930039827 | Bartholomew Drug Company | DME SUPPLIER - PHARMACY |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 315 S Main St, Rock Port, Missouri |
| Zip: | 64482-1533 |
| Phone Number: | 660-744-2343 |
| Fax Number: | 660-744-2433 |
Patients can reach Bartholomew Drug Company at
315 S Main St, Rock Port, Missouri or can
call on customer care at 660-744-2343.
Comments/ Reviews:
Read all the reviews posted for Bartholomew Drug Company below. You may also share your own experience with Bartholomew Drug Company. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.